Pacific Biosciences of California Inc. buy The Goldman Sachs Group, Inc.
Start price
10.04.24
/
50%
€3.26
Target price
10.04.25
€6.50
Performance (%)
-52.46%
Price
30.04.24
€1.55
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr for Pacific Biosciences of California Inc. is performing very badly with a performance of -52.46%. This prediction currently runs until 10.04.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Pacific Biosciences of California Inc. | 22.426% |
iShares Core DAX® | -0.992% |
iShares Nasdaq 100 | -0.225% |
iShares Nikkei 225® | -0.736% |
iShares S&P 500 | -0.509% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $9.00 to $7.00. They now have a "buy" rating on the stock.
Ratings data for PACB provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€12.81
30.06.23
30.06.23
€15.60
30.06.24
30.06.24
-87.90%
30.04.24
30.04.24